- Home
- OCGN vs PCYO Comparison
OCGN vs PCYO Comparison
Compare OCGN & PCYO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- OCGN
- PCYO
- Stock Information
- Founded
- OCGN 2013
- PCYO 1976
- Country
- OCGN United States
- PCYO United States
- Employees
- OCGN N/A
- PCYO N/A
- Industry
- OCGN Biotechnology: Biological Products (No Diagnostic Substances)
- PCYO Water Supply
- Sector
- OCGN Health Care
- PCYO Utilities
- Exchange
- OCGN Nasdaq
- PCYO Nasdaq
- Market Cap
- OCGN 321.7M
- PCYO 267.7M
- IPO Year
- OCGN N/A
- PCYO N/A
- Fundamental
- Price
- OCGN $1.79
- PCYO $11.10
- Analyst Decision
- OCGN Strong Buy
- PCYO
- Analyst Count
- OCGN 3
- PCYO 0
- Target Price
- OCGN $6.00
- PCYO N/A
- AVG Volume (30 Days)
- OCGN 7.9M
- PCYO 39.8K
- Earning Date
- OCGN 11-07-2025
- PCYO 11-12-2025
- Dividend Yield
- OCGN N/A
- PCYO N/A
- EPS Growth
- OCGN N/A
- PCYO 123.89
- EPS
- OCGN N/A
- PCYO 0.56
- Revenue
- OCGN $4,754,000.00
- PCYO $27,447,000.00
- Revenue This Year
- OCGN N/A
- PCYO N/A
- Revenue Next Year
- OCGN N/A
- PCYO N/A
- P/E Ratio
- OCGN N/A
- PCYO $19.74
- Revenue Growth
- OCGN N/A
- PCYO 40.36
- 52 Week Low
- OCGN $0.52
- PCYO $9.65
- 52 Week High
- OCGN $1.90
- PCYO $14.63
- Technical
- Relative Strength Index (RSI)
- OCGN 70.01
- PCYO 54.73
- Support Level
- OCGN $1.31
- PCYO $11.03
- Resistance Level
- OCGN $1.85
- PCYO $11.33
- Average True Range (ATR)
- OCGN 0.14
- PCYO 0.26
- MACD
- OCGN 0.02
- PCYO -0.04
- Stochastic Oscillator
- OCGN 78.81
- PCYO 24.05
About OCGN Ocugen Inc.
Ocugen Inc company focused on discovering, developing, and commercializing novel gene and cell therapies and vaccines that improve health and offer hope for patients across the globe. The company's pipeline includes Modifier Gene Therapy Platform, Novel Biologic Therapy for Retinal Diseases, Regenerative Medicine Cell Therapy Platform, Inhaled Mucosal Vaccine Platform. The company is developing a modifier gene therapy platform designed to fulfill unmet medical needs related to retinal diseases, including inherited retinal diseases ("IRDs"), such as RP, LCA, Stargardt disease, and multifactorial diseases such as dAMD and Geographic Atrophy ("GA").
About PCYO Pure Cycle Corporation
Pure Cycle Corp is a diversified land and water resource development company. The company designs, constructs, manages, operates, and maintains water and wastewater systems. The firm operates in two business segments namely Water and wastewater resource development and Land development. It generates maximum revenue from the Land development segment. The land resource development segment includes all the activities necessary to develop and sell finished lots.